batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. LigaChem’s L1CAM flip 10 October 2024 Keytruda could advance in head and neck 9 October 2024 J&J’s Sunrise dims 8 October 2024 Black Diamond goes all in on EGFR 8 October 2024 Opdivo approval might be good news for Astra 4 October 2024 Genmab takes on AbbVie’s Elahere 3 October 2024 FDA red and green lights: September 2024 2 October 2024 Bristol makes a quick pivotal move in multiple myeloma 2 October 2024 Load More